Targeting G1S-checkpoint-compromised cancers with cyclin A/B RxL...

shared a link to vibe with.

2025-08-20 18:36:03 -

WWW.NATURE.COM

Targeting G1S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors

Nature, Published online: 20 August 2025; doi:10.1038/s41586-025-09433-wDual cyclin A/B RxL inhibitors selectively kill small cell lung cancer cells and other cancer cells with high E2F activity.

0 Σχόλια 0 Μοιράστηκε 42 Views 0 Προεπισκόπηση